Viewing StudyNCT04822818



Ignite Creation Date: 2024-05-06 @ 3:58 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04822818
Status: COMPLETED
Last Update Posted: 2022-12-28
First Post: 2021-03-25

Brief Title: EFFICACY and SAFETY OF BEVACIZUMAB ZIRABEV IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization: Assistance Publique - Hôpitaux de Paris

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-17
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-10
Primary Completion Date Type: ACTUAL
Completion Date: 2022-07-11
Completion Date Type: ACTUAL
First Submit Date: 2021-03-25
First Submit QC Date: March 29 2021
Study First Post Date: 2021-03-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-12-26
Last Update Post Date: 2022-12-28
Last Update Post Date Type: ACTUAL